Why Market Size Forecasters?
- Reports at Lowest Prices - Guaranteed
- Fastest Growing Research Reports’ Database
- Easy Customization Options
- 24 X 7 Support Commitment
- Certified, Safe & Secured Payments
About DNA Probe-based Diagnostic The DNA probe is a basic component in most molecular diagnostic techniques. The DNA probe is a labeled DNA strand synthesized in the laboratory. Its purpose is to hybridize with the target nucleic acid molecule to be identified from a biological sample. A probe is composed of a strand of 30-40 nucleotides called oligonucleotides. These oligonucleotides are labeled with a detector molecule. When hybridization occurs between the probe and the target organism's nucleic acid, the hybrid can be detected through the detector molecule. Technavio?s analysts forecast the global DNA probe-based diagnostic market to grow at a CAGR of 10.95% during the period 2017-2021. Covered in this report The report covers the present scenario and the growth prospects of the global DNA probe-based diagnostic market for 2017-2021. To calculate the market size, the report considers the revenue generated from the retail sale of DNA probe-based diagnostic products. The market is divided into the following segments based on geography: ? Americas ? APAC ? EMEA Technavio's report, Global DNA Probe-based Diagnostic Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors ? Abbott Laboratories ? F. Hoffmann La Roche ? GE Healthcare ? Thermo Fisher Scientific Other prominent vendors ? BD ? Biogenex ? bioMerieux ? Biolegio ? Luminex ? MP Biomedicals Market driver ? Growing incidence and prevalence of cancer ? For a full, detailed list, view our report Market challenge ? Highly complex technique ? For a full, detailed list, view our report Market trend ? Advancement in DNA array ? For a full, detailed list, view our report Key questions answered in this report ? What will the market size be in 2021 and what will the growth rate be? ? What are the key market trends? ? What is driving this market? ? What are the challenges to market growth? ? Who are the key vendors in this market space? You can request one free hour of our analyst?s time when you purchase this market report. Details are provided within the report.
Table of Contents PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: INTRODUCTION ? Market outline PART 05: MARKET LANDSCAPE ? Market size and forecast ? Five forces analysis PART 06: MARKET SEGMENTATION BY APPLICATION ? Global DNA probe-based diagnostics market by application ? Global DNA probe-based diagnostics market by infectious disease testing ? Global DNA probe-based diagnostics market by cancer testing ? Global DNA probe-based diagnostics market by others PART 07: REGIONAL LANDSCAPE ? Geographical segmentation ? Regional comparison ? DNA probe-based diagnostics market in Americas ? DNA probe-based diagnostics market in EMEA ? DNA probe-based diagnostics market in APAC ? Market opportunity PART 08: DECISION FRAMEWORK PART 09: DRIVERS AND CHALLENGES ? Market drivers ? Market challenges PART 10: MARKET TRENDS ? Advancement in DNA array ? Increase in molecular research activities ? Increasing importance of promotional activities ? Increasing prominence of DNA probe technology in diagnosing vaginitis PART 11: VENDOR LANDSCAPE ? Competitive scenario ? Investment opportunity PART 12: KEY VENDOR ANALYSIS ? Abbott Laboratories ? F. Hoffmann La Roche ? GE Healthcare ? Thermo Fisher Scientific ? Other prominent vendors PART 13: APPENDIX ? List of abbreviations List of Exhibits Exhibit 01: Primary types of DNA probe assays used for diagnosis Exhibit 02: Several diagnostic areas depending on DNA probe-based technology Exhibit 03: Global DNA probe-based diagnostics market: Market overview Exhibit 04: Global DNA probe-based diagnostics market 2016-2021 ($ billions) Exhibit 05: Factors impacting the global DNA probe-based diagnostics market Exhibit 06: Five forces analysis Exhibit 07: Global DNA probe-based diagnostics market by application 2016-2021 (% share) Exhibit 08: Global DNA probe-based diagnostics market by infectious disease testing 2016-2021 ($ billions) Exhibit 09: Global DNA probe-based diagnostics market by cancer testing 2016-2021 ($ billions) Exhibit 10: Global DNA probe-based diagnostics market by others 2016-2021 ($ billions) Exhibit 11: Geographical segmentation 2016-2021? Market share Exhibit 12: Regional comparison Exhibit 13: DNA probe-based diagnostics market in Americas 2016-2021 ($ billions) Exhibit 14: DNA probe-based diagnostics market in Americas: Year-over-year growth Exhibit 15: Top 3 countries in Americas Exhibit 16: DNA probe-based diagnostics market in EMEA 2016-2021 ($ billions) Exhibit 17: DNA probe-based diagnostics market in EMEA: Year-over-year growth Exhibit 18: Top 3 countries in EMEA Exhibit 19: DNA probe-based diagnostics market in APAC 2016-2021 ($ billions) Exhibit 20: DNA probe-based diagnostics market in APAC: Year-over-year growth Exhibit 21: Top 3 countries in APAC Exhibit 22: Some examples of infectious diseases caused by pathogenic microorganisms Exhibit 23: Strategic success factors for vendors Exhibit 24: Investment opportunity mapping Exhibit 25: Abbott Laboratories: Profile Exhibit 26: Abbott Laboratories: Strength analysis Exhibit 27: Abbott Laboratories: Strategy assessment Exhibit 28: Abbott Laboratories: Opportunity assessment Exhibit 29: F. Hoffmann-La Roche: Profile Exhibit 30: F. Hoffmann-La Roche : Strength analysis Exhibit 31: F. Hoffmann-La Roche strategy assessment Exhibit 32: F. Hoffmann-La Roche opportunity assessment Exhibit 33: GE Healthcare: Profile Exhibit 34: GE Healthcare: Strength analysis Exhibit 35: GE Healthcare: Strategy assessment Exhibit 36: GE Healthcare: Opportunity assessment Exhibit 37: Thermo Fisher Scientific: Profile Exhibit 38: Thermo Fisher Scientific: Strength analysis Exhibit 39: Thermo Fisher Scientific: Strategy assessment Exhibit 40: Thermo Fisher Scientific: Opportunity assessment
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
Primary research - Manufacturers/Suppliers, Channel partners, Industry experts, Strategic decision makers
Secondary research - Technavio internal repository, Industry journals and periodicals, Government bodies, Annual reports of key stakeholders
Data synthesis - Collation of data, Estimation of key figure, Analysis of derived insights
Data validation - Triangulation with data models, Reference against proprietary databases, Corroboration with industry experts
Qualitative analysis - Market drivers, Market challenges, Market trends, Five forces analysis
Quantitative analysis- Market size and forecast, Market segmentation, Geographical insights, Competitive landscape
Technavio’s database and industry-specific repositories are used for defining the hypothesis for the study, which is further fine-tuned through primary research involving industry experts. The success of our approach lies in the fact that we take the viewpoint of all stakeholders into consideration while analyzing an industry, and objectively assess each outlook.
Why Market Size Forecasters?